Beck Bode LLC’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-28,875
| Closed | -$11.7M | – | 141 |
|
|
2023
Q4 | $11.7M | Buy |
28,875
+21,934
| +316% | +$8.92M | 2.64% | 4 |
|
|
2023
Q3 | $2.41M | Sell |
6,941
-112
| -2% | -$38.9K | 0.62% | 52 |
|
|
2023
Q2 | $2.48M | Sell |
7,053
-403
| -5% | -$142K | 0.6% | 55 |
|
|
2023
Q1 | $2.35M | Sell |
7,456
-1,191
| -14% | -$375K | 0.58% | 58 |
|
|
2022
Q4 | $2.5M | Buy |
8,647
+1,371
| +19% | +$396K | 0.56% | 59 |
|
|
2022
Q3 | $2.11M | Buy |
7,276
+2,342
| +47% | +$678K | 0.46% | 65 |
|
|
2022
Q2 | $1.39M | Buy |
4,934
+4,065
| +468% | +$1.15M | 0.3% | 75 |
|
|
2022
Q1 | $227K | Buy |
+869
| New | +$227K | 0.05% | 143 |
|
|
2021
Q4 | – | Sell |
-53,823
| Closed | -$9.76M | – | 104 |
|
|
2021
Q3 | $9.76M | Buy |
53,823
+53,813
| +538,130% | +$9.76M | 2.72% | 15 |
|
|
2021
Q2 | $2K | Buy |
+10
| New | +$2K | ﹤0.01% | 303 |
|
|
2020
Q4 | – | Sell |
-387
| Closed | -$105K | – | 270 |
|
|
2020
Q3 | $105K | Buy |
+387
| New | +$105K | 0.04% | 78 |
|